Fulcrum Therapeutics (FULC) Return on Capital Employed Growth (3y) (2022 - 2026)
Fulcrum Therapeutics (FULC) Return on Capital Employed Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | -3,782.00 |
| 10 | Fulcrum Therapeutics | 287.33 Mn | 287.33 Mn | - | 1,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,916.00 |
| Dec 31, 2025 | 2,050.00 |
| Sep 30, 2025 | 1,352.00 |
| Jun 30, 2025 | 1,895.00 |
| Mar 31, 2025 | 3,788.00 |
| Dec 31, 2024 | 2,739.00 |
| Sep 30, 2024 | 3,155.00 |
| Jun 30, 2024 | 4,598.00 |
| Mar 31, 2024 | 1,001.00 |
| Dec 31, 2023 | 2,213.00 |
| Sep 30, 2023 | 1,990.00 |
| Jun 30, 2023 | 2,806.00 |
| Mar 31, 2023 | 3,024.00 |
| Dec 31, 2022 | 3,229.00 |
| Sep 30, 2022 | 4,162.00 |